1. Generics Bulletin
  2. >>Leadership

Reed Sets Out Priorities For US Biosimilars Forum

New Executive Director Julie Reed Also Highlights Benefits Of Diverse Membership

 
• By Dave Wallace

In an exclusive interview with Generics Bulletin, the Biosimilars Forum’s executive director Julie Reed sets out the group’s priorities and explains how its diverse membership is helping to position it as a leading voice for the US biosimilars industry.

Speech Balloons Diverse Voices
The Biosimilars Forum represents a range of industry voices • Source: Kristaps Eberlins / Alamy Stock Vector

With biosimilars taking on an increasingly prominent role in the US, Biosimilars Forum leader Julie Reed believes that they can offer a “ready-made solution” to current healthcare pressures. 

However, Reed highlighted in an exclusive interview with Generics Bulletin as she moved from being president of the Forum to executive director, a number of key aspects around access, regulation, education and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Generics Bulletin

Apotex Extends Formosa Ophthalmic Alliance Into Mexico

 
• By Dave Wallace

Apotex has expanded an alliance formed with Formosa in August for its novel clobetasol propionate ophthalmic treatment, adding Mexican rights to its existing deal for the Canadian market.

Fresenius Kabi Lauds Tocilizumab Momentum As ‘Intense’ Transfer To mAbxience Continues

 
• By Dean Rudge

Fresenius Kabi continued to reap the rewards of its fledgling commercial Biopharma business in the first quarter, as the firm eyes further growth for its tocilizumab biosimilar in the US and Europe in the second half of 2025.

US FDA Expands Surprise Foreign Inspections

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.